Alexion Pharmaceuticals Total Assets 2006-2021 | ALXN

Alexion Pharmaceuticals total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Alexion Pharmaceuticals total assets for the quarter ending March 31, 2021 were $18.650B, a 2.76% increase year-over-year.
  • Alexion Pharmaceuticals total assets for 2020 were $18.103B, a 3.18% increase from 2019.
  • Alexion Pharmaceuticals total assets for 2019 were $17.545B, a 25.93% increase from 2018.
  • Alexion Pharmaceuticals total assets for 2018 were $13.932B, a 2.57% increase from 2017.
Alexion Pharmaceuticals Annual Total Assets
(Millions of US $)
2020 $18,103
2019 $17,545
2018 $13,932
2017 $13,583
2016 $13,253
2015 $13,097
2014 $4,202
2013 $3,318
2012 $2,614
2011 $1,395
2010 $1,012
2009 $786
2008 $478
2007 $334
2006 $334
2005 $248
Alexion Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2021-03-31 $18,650
2020-12-31 $18,103
2020-09-30 $17,548
2020-06-30 $16,703
2020-03-31 $18,149
2019-12-31 $17,545
2019-09-30 $14,815
2019-06-30 $14,568
2019-03-31 $14,000
2018-12-31 $13,932
2018-09-30 $13,844
2018-06-30 $13,490
2018-03-31 $13,830
2017-12-31 $13,583
2017-09-30 $13,643
2017-06-30 $13,489
2017-03-31 $13,435
2016-12-31 $13,253
2016-09-30 $13,293
2016-06-30 $13,029
2016-03-31 $12,802
2015-12-31 $13,097
2015-09-30 $13,153
2015-06-30 $13,168
2015-03-31 $4,415
2014-12-31 $4,202
2014-09-30 $3,891
2014-06-30 $3,554
2014-03-31 $3,380
2013-12-31 $3,318
2013-09-30 $3,050
2013-06-30 $2,815
2013-03-31 $2,686
2012-12-31 $2,614
2012-09-30 $2,506
2012-06-30 $2,458
2012-03-31 $2,017
2011-12-31 $1,395
2011-09-30 $1,305
2011-06-30 $1,180
2011-03-31 $1,155
2010-12-31 $1,012
2010-09-30 $942
2010-06-30 $890
2010-03-31 $836
2009-12-31 $786
2009-09-30 $552
2009-06-30 $515
2009-03-31 $492
2008-12-31 $478
2008-09-30 $430
2008-06-30 $379
2008-03-31 $364
2007-12-31 $334
2007-09-30 $321
2007-06-30 $297
2007-03-31 $308
2006-12-31 $334
2006-09-30 $211
2006-06-30 $215
2006-03-31 $238
2005-12-31 $263
2005-10-31 $281
2005-09-30 $0
2005-07-31 $248
2005-06-30 $0
2005-04-30 $281
2005-03-31 $0
2005-01-31 $425
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $39.777B $6.070B
Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition and has developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG). In addition, Alexion has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D).
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $149.087B 10.34
Amgen (AMGN) United States $138.330B 14.93
CSL (CSLLY) Australia $104.641B 0.00
Gilead Sciences (GILD) United States $84.306B 8.97
Moderna (MRNA) United States $81.297B 161.98
Illumina (ILMN) United States $66.481B 95.86
Biogen (BIIB) United States $57.741B 13.22
Regeneron Pharmaceuticals (REGN) United States $57.109B 16.35
BioNTech SE (BNTX) Germany $51.734B 37.51
Vertex Pharmaceuticals (VRTX) United States $48.760B 20.08
BeiGene (BGNE) Cayman Islands $30.286B 0.00
Genmab (GMAB) Denmark $28.565B 33.49
Seagen (SGEN) United States $27.835B 48.08
Genmab (GNMSF) Denmark $27.247B 6.27
Exact Sciences (EXAS) United States $21.770B 0.00
Horizon Therapeutics Public (HZNP) Ireland $20.710B 26.48
Alnylam Pharmaceuticals (ALNY) United States $20.247B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Incyte (INCY) United States $18.282B 36.14
Bio-Techne Corp (TECH) United States $17.314B 91.04
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
ARGENX SE-ADR (ARGX) Netherlands $16.157B 0.00
Zai Lab (ZLAB) China $15.289B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.164B 138.30
Novavax (NVAX) United States $13.329B 0.00
Guardant Health (GH) United States $12.508B 0.00
Repligen (RGEN) United States $10.961B 98.83
CureVac (CVAC) Germany $10.809B 0.00
QIAGEN (QGEN) Netherlands $10.663B 18.93
CRISPR Therapeutics AG (CRSP) Switzerland $9.643B 0.00
Denali Therapeutics (DNLI) United States $9.066B 325.26
Mirati Therapeutics (MRTX) United States $8.573B 0.00
Fate Therapeutics (FATE) United States $7.919B 0.00
Acceleron Pharma (XLRN) United States $7.728B 0.00
Ascendis Pharma (ASND) Denmark $7.428B 0.00
Exelixis (EXEL) United States $6.935B 110.65
Ultragenyx Pharmaceutical (RARE) United States $6.477B 0.00
Sarepta Therapeutics (SRPT) United States $6.389B 0.00
AbCellera Biologics (ABCL) $6.180B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $6.135B 0.00
Halozyme Therapeutics (HALO) United States $6.114B 33.55
Vir Biotechnology (VIR) United States $5.698B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.628B 20.39
Adaptive Biotechnologies (ADPT) United States $5.587B 0.00
Twist Bioscience (TWST) United States $5.547B 0.00
I-Mab (IMAB) China $5.407B 0.00
Beam Therapeutics (BEAM) United States $5.319B 0.00
Intellia Therapeutics (NTLA) United States $5.214B 0.00
Legend Biotech (LEGN) United States $5.155B 0.00
NeoGenomics (NEO) United States $5.139B 871.60
Reata Pharmaceuticals (RETA) United States $5.073B 0.00
Galapagos (GLPG) Belgium $4.984B 0.00
Blueprint Medicines (BPMC) United States $4.873B 14.84
Apellis Pharmaceuticals (APLS) United States $4.814B 0.00
Certara (CERT) United States $4.212B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.141B 0.00
Arena Pharmaceuticals (ARNA) United States $4.030B 0.00
Alkermes (ALKS) Ireland $3.962B 0.00
SpringWorks Therapeutics (SWTX) United States $3.893B 0.00
Arvinas (ARVN) United States $3.853B 0.00
Intra-Cellular Therapies (ITCI) United States $3.505B 0.00
Emergent Biosolutions (EBS) United States $3.382B 6.74
Berkeley Lights (BLI) United States $3.296B 0.00
Insmed (INSM) United States $3.025B 0.00
Vericel (VCEL) United States $2.827B 762.25
BAVARIAN NORDIC (BVNRY) Denmark $2.811B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.751B 0.00
Amicus Therapeutics (FOLD) United States $2.714B 0.00
MorphoSys AG (MOR) Germany $2.630B 0.00
Sorrento Therapeutics (SRNE) United States $2.492B 0.00
Editas Medicine (EDIT) United States $2.453B 0.00
ALX Oncology Holdings (ALXO) United States $2.426B 0.00
Heska (HSKA) United States $2.395B 1044.14
Myriad Genetics (MYGN) United States $2.363B 0.00
Morphic Holding (MORF) United States $2.342B 0.00
Instil Bio (TIL) United States $2.325B 0.00
Global Blood Therapeutics (GBT) United States $2.309B 0.00
Bluebird Bio (BLUE) United States $2.224B 0.00
Revance Therapeutics (RVNC) United States $2.197B 0.00
Bionano Genomics (BNGO) United States $2.192B 0.00
Prothena (PRTA) Ireland $2.152B 0.00
Kymera Therapeutics (KYMR) United States $2.146B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.135B 0.00
Ligand Pharmaceuticals (LGND) United States $2.128B 35.60
Seer (SEER) $2.069B 0.00
Amarin (AMRN) Ireland $1.946B 0.00
Seres Therapeutics (MCRB) United States $1.916B 0.00
Castle Biosciences (CSTL) United States $1.907B 0.00
Myovant Sciences (MYOV) United Kingdom $1.896B 0.00
Protagonist Therapeutics (PTGX) United States $1.896B 0.00
Atea Pharmaceuticals (AVIR) United States $1.891B 0.00
Inovio Pharmaceuticals (INO) United States $1.847B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.817B 0.00
PHARMA MAR SA (PHMMF) Spain $1.777B 0.00
Genetron Holdings (GTH) China $1.767B 0.00
Zymeworks (ZYME) Canada $1.763B 0.00
Alector (ALEC) United States $1.705B 0.00
Arcus Biosciences (RCUS) United States $1.688B 0.00
Sangamo Therapeutics (SGMO) United States $1.647B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.640B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.626B 0.00
REGENXBIO (RGNX) United States $1.611B 0.00
C4 Therapeutics (CCCC) United States $1.602B 0.00
UniQure (QURE) Netherlands $1.588B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.585B 0.00
Cytokinetics (CYTK) United States $1.574B 0.00
NGM Biopharmaceuticals (NGM) United States $1.531B 0.00
PureTech Health (PRTC) United States $1.462B 0.00
Avid Bioservices (CDMO) United States $1.442B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.372B 0.00
Zealand Pharma (ZEAL) Denmark $1.348B 0.00
MiMedx (MDXG) United States $1.342B 0.00
Nurix Therapeutics (NRIX) United States $1.316B 0.00
Northwest Biotherapeutics (NWBO) United States $1.316B 0.00
Precigen (PGEN) United States $1.313B 0.00
Ocugen (OCGN) United States $1.296B 0.00
BioAtla (BCAB) United States $1.292B 0.00
Codexis (CDXS) United States $1.267B 0.00
Repare Therapeutics (RPTX) Canada $1.255B 0.00
Shattuck Labs (STTK) United States $1.245B 0.00
Keros Therapeutics (KROS) United States $1.224B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.201B 0.00
Agenus (AGEN) United States $1.183B 0.00
Zealand Pharma (ZLDPF) Denmark $1.135B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.123B 0.00
Celldex Therapeutics (CLDX) United States $1.109B 0.00
MannKind (MNKD) United States $1.106B 0.00
Pliant Therapeutics (PLRX) United States $1.096B 0.00
Coherus BioSciences (CHRS) United States $1.089B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.086B 34.30
Mesoblast (MESO) Australia $1.081B 0.00
Scholar Rock Holding (SRRK) United States $1.061B 0.00
Dynavax Technologies (DVAX) United States $1.036B 0.00
Prometheus Biosciences (RXDX) United States $1.034B 0.00
Avidity Biosciences (RNA) United States $1.008B 0.00
VBI Vaccines (VBIV) United States $1.004B 0.00
Mersana Therapeutics (MRSN) United States $0.998B 0.00
Inhibrx (INBX) United States $0.979B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.944B 0.00
Travere Therapeutics (TVTX) United States $0.929B 0.00
G1 THERAPEUTICS (GTHX) United States $0.924B 0.00
Epizyme (EPZM) United States $0.898B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.892B 0.00
Cel-Sci (CVM) United States $0.885B 0.00
Sutro Biopharma (STRO) United States $0.864B 0.00
RAPT THERAPTICS (RAPT) United States $0.835B 0.00
Nkarta (NKTX) United States $0.832B 0.00
Verastem (VSTM) United States $0.820B 0.00
Merus (MRUS) Netherlands $0.805B 0.00
Affimed (AFMD) Germany $0.792B 0.00
SESEN BIO, INC (SESN) United States $0.780B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 20.00
IDEAYA Biosciences (IDYA) United States $0.748B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.744B 0.00
Pharming Group (PHAR) Netherlands $0.740B 0.00
Cara Therapeutics (CARA) United States $0.733B 63.70
Kadmon Holdings (KDMN) United States $0.719B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.715B 0.00
Curis (CRIS) United States $0.698B 0.00
Clene (CLNN) United States $0.690B 0.00
Cellectis S.A (CLLS) France $0.687B 0.00
DBV Technologies S.A (DBVT) France $0.687B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.684B 0.00
AnaptysBio (ANAB) United States $0.683B 0.00
ChromaDex (CDXC) United States $0.679B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.671B 0.00
MeiraGTx Holdings (MGTX) United States $0.665B 0.00
ALBIREO PHARMA (ALBO) United States $0.655B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.655B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.650B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Clovis Oncology (CLVS) United States $0.637B 0.00
Precision BioSciences (DTIL) United States $0.613B 0.00
Adagene (ADAG) China $0.609B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.599B 0.00
Anika Therapeutics (ANIK) United States $0.591B 0.00
Bolt Biotherapeutics (BOLT) United States $0.583B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.582B 0.00
Selecta Biosciences (SELB) United States $0.563B 0.00
Inventiva S.A (IVA) France $0.562B 0.00
Codiak BioSciences (CDAK) United States $0.552B 0.00
AC Immune SA (ACIU) Switzerland $0.541B 0.00
Forte Biosciences (FBRX) United States $0.540B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.537B 0.00
Compugen (CGEN) Israel $0.534B 0.00
Starpharma Holdings (SPHRY) Australia $0.506B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.496B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Gritstone Bio (GRTS) United States $0.487B 0.00
XBiotech (XBIT) United States $0.486B 0.00
CytomX Therapeutics (CTMX) United States $0.466B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.460B 0.00
Athenex (ATNX) United States $0.454B 0.00
Oncobiologics (OTLK) United States $0.451B 0.00
Spero Therapeutics (SPRO) United States $0.450B 0.00
Geron (GERN) United States $0.449B 0.00
BeyondSpring (BYSI) United States $0.443B 0.00
Neoleukin Therapeutics (NLTX) United States $0.434B 0.00
AquaBounty Technologies (AQB) United States $0.423B 0.00
Amryt Pharma (AMYT) United Kingdom $0.421B 0.00
ANI Pharmaceuticals (ANIP) United States $0.417B 11.51
Kindred Biosciences (KIN) United States $0.416B 0.00
Cue Biopharma (CUE) United States $0.412B 0.00
Puma Biotechnology (PBYI) United States $0.412B 0.00
Opthea (OPT) Australia $0.395B 0.00
Angion Biomedica (ANGN) United States $0.395B 0.00
SQZ Biotechnologies (SQZ) United States $0.384B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.382B 0.00
Kala Pharmaceuticals (KALA) United States $0.380B 0.00
Adverum Biotechnologies (ADVM) United States $0.365B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.361B 0.00
WAVE Life Sciences (WVE) Singapore $0.357B 0.00
BioDelivery Sciences (BDSI) United States $0.355B 14.40
UROGEN PHARMA (URGN) United States $0.351B 0.00
Fortress Biotech (FBIO) United States $0.350B 0.00
Cogent Biosciences (COGT) United States $0.349B 0.00
Syros Pharmaceuticals (SYRS) United States $0.348B 0.00
XOMA (XOMA) United States $0.347B 162.16
Frequency Therapeutics (FREQ) United States $0.347B 0.00
Athersys (ATHX) United States $0.344B 0.00
Theratechnologies (THTX) Canada $0.341B 0.00
Prima BioMed (IMMP) Australia $0.339B 0.00
Cerecor (CERC) United States $0.336B 0.00
IBio (IBIO) United States $0.335B 0.00
Adicet Bio (ACET) United States $0.334B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.320B 0.00
Arbutus Biopharma (ABUS) United States $0.314B 0.00
Trevena (TRVN) United States $0.311B 0.00
OVID THERAPEUTC (OVID) United States $0.302B 2.97
CorMedix Inc (CRMD) United States $0.299B 0.00
Cardiff Oncology (CRDF) United States $0.294B 0.00
Innate Pharma S.A (IPHA) France $0.293B 0.00
Kaleido Biosciences (KLDO) $0.287B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Fulcrum Therapeutics (FULC) United States $0.280B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.276B 0.00
Bellus Health (BLU) Canada $0.268B 0.00
Clearside Biomedical (CLSD) United States $0.267B 0.00
Talis Biomedical (TLIS) United States $0.261B 0.00
INmune Bio (INMB) United States $0.260B 0.00
Kamada (KMDA) Israel $0.257B 17.51
HOOKIPA Pharma (HOOK) United States $0.252B 0.00
Seelos Therapeutics (SEEL) United States $0.248B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.241B 0.00
Chiasma (CHMA) United States $0.239B 0.00
ADMA Biologics Inc (ADMA) United States $0.229B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.228B 0.00
Synlogic (SYBX) United States $0.227B 0.00
NextCure (NXTC) United States $0.226B 0.00
Checkpoint Therapeutics (CKPT) United States $0.223B 0.00
Aptinyx (APTX) United States $0.222B 0.00
TELA Bio (TELA) United States $0.217B 0.00
VTv Therapeutics (VTVT) United States $0.200B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Strongbridge Biopharma (SBBP) United States $0.192B 0.00
X4 Pharmaceuticals (XFOR) United States $0.192B 0.00
Biofrontera AG (BFRA) Germany $0.189B 0.00
Applied Genetic Technologies (AGTC) United States $0.188B 0.00
OSMOTICA PHARM (OSMT) United States $0.184B 0.00
GENFIT S.A (GNFT) France $0.182B 0.00
PHASEBIO PHARMA (PHAS) United States $0.181B 0.00
Voyager Therapeutics (VYGR) United States $0.175B 4.51
VolitionRX (VNRX) United States $0.175B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.174B 0.00
Galena Biopharma (SLS) United States $0.173B 0.00
ObsEva SA (OBSV) Switzerland $0.171B 0.00
Nicox SA (NICXF) France $0.171B 0.00
Abeona Therapeutics (ABEO) United States $0.169B 0.00
Eton Pharmaceuticals (ETON) United States $0.154B 0.00
Antibe Therapeutics (ATBPF) Canada $0.153B 0.00
DiaMedica Therapeutics (DMAC) United States $0.150B 0.00
Cyclerion Therapeutics (CYCN) United States $0.149B 0.00
Exicure (XCUR) United States $0.147B 0.00
Enzo Biochem (ENZ) United States $0.141B 41.43
Eyenovia (EYEN) United States $0.140B 0.00
Liquidia Technologies (LQDA) United States $0.139B 0.00
Catalyst Biosciences (CBIO) United States $0.139B 0.00
Novogen (KZIA) Australia $0.137B 0.00
Longeveron (LGVN) United States $0.135B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.134B 0.00
LogicBio Therapeutics (LOGC) United States $0.132B 0.00
Palatin Technologies (PTN) United States $0.132B 0.00
Erytech Pharma SA (ERYP) France $0.132B 0.00
ABVC BioPharma (ABVC) United States $0.127B 0.00
Cocrystal Pharma (COCP) United States $0.127B 0.00
Aptevo Therapeutics (APVO) United States $0.126B 0.00
Yumanity Therapeutics (YMTX) United States $0.126B 0.00
Aytu BioPharma (AYTU) United States $0.125B 0.00
Liminal BioSciences (LMNL) Canada $0.125B 0.00
Pluristem Therapeutics (PSTI) Israel $0.124B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.124B 0.00
Entera Bio (ENTX) Israel $0.123B 0.00
Evofem Biosciences (EVFM) United States $0.119B 0.00
Orgenesis (ORGS) United States $0.119B 243.50
Beyond Air (XAIR) United States $0.117B 0.00
Vyant Bio (VYNT) United States $0.115B 0.00
Celsion (CLSN) United States $0.114B 0.00
Vascular Biogenics (VBLT) Israel $0.112B 0.00
AEterna Zentaris (AEZS) United States $0.110B 0.00
Zosano Pharma (ZSAN) United States $0.106B 0.00
Armata Pharmaceuticals (ARMP) United States $0.104B 0.00
Leap Therapeutics (LPTX) United States $0.103B 0.00
CytRx (CYTR) United States $0.103B 0.00
TRACON Pharmaceuticals (TCON) United States $0.102B 0.00
ARAVIVE, INC (ARAV) United States $0.101B 0.00
Cidara Therapeutics (CDTX) United States $0.101B 0.00
Evogene (EVGN) Israel $0.097B 0.00
Dyadic (DYAI) United States $0.095B 0.00
Protalix BioTherapeutics (PLX) Israel $0.093B 0.00
AIkido Pharma (AIKI) United States $0.090B 0.00
Lumos Pharma (LUMO) United States $0.090B 0.00
Purple Biotech (PPBT) Israel $0.089B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.089B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.085B 0.00
BioCardia (BCDA) United States $0.081B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Vaccinex (VCNX) United States $0.077B 0.00
Adocia (ADOCY) France $0.077B 0.00
ARIDIS PHARMACT (ARDS) United States $0.076B 0.00
Edesa Biotech (EDSA) Canada $0.076B 0.00
Celyad SA (CYAD) Belgium $0.075B 0.00
Cleveland BioLabs (CBLI) United States $0.075B 0.00
ATyr Pharma (LIFE) United States $0.075B 0.00
Viridian Therapeutics (VRDN) United States $0.072B 0.00
Advaxis (ADXS) United States $0.071B 0.00
Alimera Sciences (ALIM) United States $0.068B 0.00
Cyclo Therapeutics (CYTH) United States $0.067B 0.00
Genetic Technologies (GENE) Australia $0.063B 0.00
Organovo Holdings (ONVO) United States $0.063B 0.00
Idera Pharmaceuticals (IDRA) United States $0.062B 0.00
Pulmatrix (PULM) United States $0.059B 0.00
Windtree Therapeutics (WINT) United States $0.058B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.057B 0.00
AnPac Bio-Medical Science (ANPC) China $0.052B 0.00
Enzon Pharmaceuticals (ENZN) United States $0.052B 0.00
Soligenix (SNGX) United States $0.048B 0.00
Enveric Biosciences (ENVB) United States $0.048B 0.00
Acorda Therapeutics (ACOR) United States $0.046B 1.11
Invo BioScience (INVO) United States $0.046B 0.00
Timber Pharmaceuticals (TMBR) United States $0.043B 0.00
Happiness Biotech Group (HAPP) China $0.041B 0.00
GeoVax Labs (GOVX) United States $0.035B 0.00
Lexaria Bioscience (LEXX) Canada $0.035B 0.00
ThermoGenesis Holdings (THMO) United States $0.034B 0.00
Benitec Biopharma (BNTC) United States $0.033B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.033B 0.00
Vallon Pharmaceuticals (VLON) United States $0.033B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.032B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
ZIVO Bioscience (ZIVO) United States $0.024B 0.00
Palisade Bio (PALI) United States $0.012B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00